Rhythm Pharmaceuticals, Inc. earnings per share and revenue

RYTM earnings per share for the last quarter are -0.55 USD whereas the estimation was -0.71 USD which accounts for 22.41% surprise. Company revenue for the same period amounts to 29.08 M USD despite the estimated figure of 28.79 M USD. Estimated earnings per share for the next quarter are -0.80 USD, and revenue is expected to reach 32.52 M USD. Also watch annual changes over time to get a bigger picture of RYTM earnings per share and revenue dynamics.